Completed A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer NCT03219333 Conditions Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +18 more Locations Alaska Urological Institute — Anchorage, Alaska, United States Arizona Oncology Associates, PC - HAL — Goodyear, Arizona, United States Mayo Clinic Arizona — Phoenix, Arizona, United States Arizona Oncology Associates, PC - HOPE — Tucson, Arizona, United States View all 81 locations View more locations Show fewer locations Loading locations... View Trial Details
